Intra Cellular Therapies | Capital Ordinário



Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.77M 4K 2024-12
Biogen USD 100K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Cytokinetics USD 118K 0 2024-12
Gilead Sciences USD 1000K 0 2024-12
Halozyme Therapeutics USD 123K 4K 2024-12
Intra Cellular Therapies USD 11K 0 2024-12
J&J USD 3.12B 0 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Prothena USD 538K 0 2024-12
RedHill Biopharma USD 34.78M 13.34M 2024-06
Supernus Pharmaceuticals USD 56K 1000 2024-12
United Therapeutics USD 800K 100K 2024-12



Intra Cellular Therapies Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.